Nanowired Human Cardiac Organoid Transplantation Enables Highly Efficient and Effective Recovery of Infarcted Hearts

Researchers showed cardiac organoids engineered with electrically conductive silicon nanowires significantly enhanced the therapeutic efficacy of hPSC-derived cardiomyocytes to treat infarcted hearts.